eISSN: 3023-6940
The New Journal of Urology
  • Home
  • Novel Hematologic Markers for Risk Stratification in Bladder Cancer Patients Receiving BCG Treatment

Article Tools

Related Subjects

E-SUBMISSION

Research Article

Novel Hematologic Markers for Risk Stratification in Bladder Cancer Patients Receiving BCG Treatment


1 Department of Urology, University of Health Sciences, Haydarpaşa Numune Training and Research Hospital, Istanbul,
Türkiye
2 Department of Urology, University of Bahçeşehir, Medical Park Göztepe Hospital, Istanbul, Türkiye


DOI : 10.33719/nju1694756
New J Urol. 2025;20(2):104-112.
Abstract

Abstract

Systemic Lupus Erythematosus(SLE) is an autoimmune disease that can involvemany or-gans and systems. Bladder  involvement  and symptoms  are  rare. In SLE mucosal involve-ment cause cystitis and with neurological in-volvement causing obstruction and neuroge-nic bladder. We report the patient who follo-wed for SLE about 12 years, irregular usage of corticosteroids, was developing  acute urinary retention 2 months 3 times, obstruction iden-tified  with pressure-flow  study, treated with a transurethral catheter and intensive corticoste-roid therapy.

Abstract

Systemic Lupus Erythematosus(SLE) is an autoimmune disease that can involvemany or-gans and systems. Bladder  involvement  and symptoms  are  rare. In SLE mucosal involve-ment cause cystitis and with neurological in-volvement causing obstruction and neuroge-nic bladder. We report the patient who follo-wed for SLE about 12 years, irregular usage of corticosteroids, was developing  acute urinary retention 2 months 3 times, obstruction iden-tified  with pressure-flow  study, treated with a transurethral catheter and intensive corticoste-roid therapy.

Creative Commons

LİMRADIGITAL